Warm Autoimmune Hemolytic Anemia epidemiology

View All

Warm Autoimmune Hemolytic Anemia (wAIHA )
Warm Autoimmune Hemolytic Anemia: A less prevalent disease with prevailing unmet needs

Warm Autoimmune Hemolytic Anemia market is anticipated to increase with a CAGR of 15.9% in the 7MM by 2030, estimates DelveInsight. In 2017, as per the estimates by DelveInsight, Warm Autoimmune Haemolytic Anemia had affected 82,045 people approximately in the 7MM. For a disease being tagged - rare, WAIHA affect...

Find More

Warm Autoimmune Ahemolytic anemia Epidemiology forecast
Warm Autoimmune Hemolytic Anemia Epidemiology forecast segmentation, treatment approaches, and WAIHA market forecast

As per DelveInsight’s Warm Autoimmune Hemolytic anemia Epidemiology forecast and analysis, WAIHA prevalence in the 7MM was estimated to be around 82,045 cases. Autoimmune hemolytic anemia (AIHA) – a rare acquired autoimmune disease – is a consequence of dysfunction in the immune system, as a consequence of which...

Find More